Back

Moderna and Merck Shares Surge After Positive Cancer Vaccine Results

Stocks of biotechnology firm Moderna and pharmaceutical giant Merck rose sharply following encouraging data from their cancer vaccine development.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Cancer vaccine: A treatment designed to stimulate the immune system to target and destroy cancer cells.
  • Biotech stock: Shares of companies focused on biotechnology-based medical and pharmaceutical research and development.
  • Clinical trial: A research study testing the safety and effectiveness of new medical treatments in humans.